ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

Rogers Reaffirms Congress’ Interest In Cancer Program; Act Renewal To “Broaden, Sustain It”

April 14, 1978

Continuing Resolution Expires March 27; NIH, NCI Hope For Budget Compromise

March 15, 2013

House Appropriations For NCI Identical (So Far) To White House Request; Slight Increase for NIH

June 24, 1988

NCAB Subcommittee Approves Concept Of Qualifying Minimums, Salary Support Limit For Core Grants

October 3, 1980

Study Uncovers New Mechanism In Class of Chemotherapy Drugs

November 30, 2012